New Oriental Education & Technology Group (NYSE:EDU) has announced a $50 million management share purchase plan, leading Oppenheimer to believe that the move demonstrates the company’s commitment to its shareholders. Moreover, the research firm believes that there is only a remote chance that the Securities and Exchange Commission inquiry will result in a restatement of financials and it keeps its Perform on the shares.
VIVUS Inc.’s (NASDAQ:VVUS) share sell-off was overdone, according to Cowen, and the stock was also mentioned positively by Bank of America Merrill.
Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) wins an approval by Kyprolis, which Deutsche Bank says ‘de-risks the Onyx story’ and further, DB thinks that it could be a $3 billion product. The firm also calculates Onyx’ merger and acquisition value at $122. Shares are rated at Deutsche Bank at Buy.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro